Abingworth as of Dec. 31, 2012
Portfolio Holdings for Abingworth
Abingworth holds 18 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation | 37.2 | $65M | 8.1M | 8.08 | |
| Supernus Pharmaceuticals (SUPN) | 14.7 | $26M | 3.6M | 7.18 | |
| Clovis Oncology | 11.9 | $21M | 1.3M | 15.99 | |
| Alnylam Pharmaceuticals (ALNY) | 11.5 | $20M | 1.1M | 18.21 | |
| Astex Pharmaceuticals | 7.4 | $13M | 4.5M | 2.90 | |
| Incyte Corporation (INCY) | 5.5 | $9.6M | 581k | 16.61 | |
| OncoGenex Pharmaceuticals | 4.5 | $7.9M | 604k | 13.04 | |
| Zogenix | 1.8 | $3.1M | 2.3M | 1.32 | |
| ISIS Pharmaceuticals | 1.6 | $2.8M | 268k | 10.45 | |
| Anthera Pharmaceuticals | 1.2 | $2.2M | 3.5M | 0.62 | |
| Exelixis (EXEL) | 1.1 | $1.9M | 415k | 4.56 | |
| alexza Pharmaceuticals | 0.8 | $1.4M | 287k | 4.95 | |
| Zalicus | 0.3 | $579k | 864k | 0.67 | |
| Cornerstone Therapeutics | 0.2 | $399k | 85k | 4.71 | |
| AVANIR Pharmaceuticals | 0.2 | $294k | 113k | 2.61 | |
| Cardiome Pharma Corp | 0.1 | $178k | 481k | 0.37 | |
| EntreMed | 0.1 | $96k | 71k | 1.36 | |
| Poniard Pharmaceuticals (PARD) | 0.0 | $10k | 4.6k | 2.19 |
